Surgical Treatment for Patent Ductus Arteriosus: Our Experience of 12 Years

Mehmet Tort1, Münacettin Ceviz1, Fehimcan Sevil2

  • 1Cardiovascular Surgery, Ataturk University School of Medicine, Erzurum, TUR.

Cureus
|June 3, 2021
PubMed

Insights

Surgically closing patent ductus arteriosus (PDA) is essential for preventing severe cardiac and pulmonary complications. Surgical intervention effectively reduces pulmonary artery pressure, particularly in isolated PDA cases.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Congenital Heart Disease

Background:

  • Patent ductus arteriosus (PDA) is a critical congenital heart defect.
  • Untreated PDA can lead to pulmonary hypertension, heart failure, and mortality.

Purpose of the Study:

  • To evaluate hemodynamic changes post-surgery in PDA patients.
  • To assess surgical techniques and outcomes in PDA treatment.
  • To compare early and late postoperative findings.

Main Methods:

  • Retrospective analysis of 126 PDA patients undergoing surgical closure (2001-2012).
  • Utilized echocardiography, angiography, and CT for diagnosis and follow-up.
  • Compared outcomes between isolated PDA and PDA with congenital heart deformities.

Main Results:

  • Pulmonary hypertension was prevalent (96.0%) preoperatively.
  • Surgical closure significantly reduced pulmonary artery pressure in both isolated and complex PDA cases.
  • Higher preoperative PAP and slower PAP reduction were observed in patients with congenital heart disease and right-left shunt.

Conclusions:

  • Surgical PDA closure is vital for preventing cardiac and pulmonary sequelae.
  • Surgical intervention effectively manages pulmonary hypertension associated with PDA.
  • While surgical methods vary, closure is consistently effective in improving patient outcomes.

Related Concept Videos